Regen BioPharma Inc (RGBP) › Shareholders' EquityRegen BioPharma Inc (RGBP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: $6332013: $251.4K2014: -$261.4K2015: -$22.0K2016: -$142.4K2017: -$7.80M2018: -$8.66M2019: -$7.70M2020: -$7.33M2021: -$9.76M2022: -$4.88M2023: -$5.10M2024: -$5.22M2025: -$6.28M-$6.28M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$6.28M-20.4%2024-$5.22M-2.2%2023-$5.10M-4.5%2022-$4.88M+49.9%2021-$9.76M-33.0%2020-$7.33M+4.7%2019-$7.70M+11.1%2018-$8.66M-11.0%2017-$7.80M-5377.0%2016-$142.4K-548.1%2015-$22.0K+91.6%2014-$261.4K-204.0%2013$251.4K+39614.5%2012$633—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share